FENC
FennecANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
Current thesis
The bull case is that Fennec is already showing real commercial proof, not just pipeline optionality: Q1 2026 revenue grew 73% year over year, the company posted modest profitability, cash rose to about $40.1 million, and management tied growth to higher PEDMARK utilization plus early field-force and HEARS program traction [#IR-2026-05-14]. Additional adult and AYA evidence-building at ASCO supports a broader opportunity if physician adoption keeps expanding [#IR-2026-05-21].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.5.
What can break
Broader AYA and adult uptake is promising but still depends on emerging clinical evidence and physician adoption beyond the original pediatric approval base [#IR-2026-05-21].
Momentum
95
Value
42
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $10.50 · Bull $14.00 · Bear $6.00
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-11 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-11 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-11
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $15.33
Why
Momentum95 · Δ7d -1.5
Value42 · Δ7d -0.1
Sentiment60 · Δ7d +58.1
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
95
34% active weight
Current posture
7d trendFlat
Δ7d
-1.5
Δ21d
+8.7
Value
42
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.1
Sentiment
60
33% active weight
Current posture
7d trendImproving
Δ7d
+58.1
Δ21d
-
Why this grade
Composite grade A. Momentum 95.0 / Value 41.7 / Sentiment 59.7
Fundamentals (TTM)As of 2026-06-11
Fundamentals (TTM)
As of 2026-06-11
Market Cap
$307.42M
Beta
0.77
Shares Out
34.15M
P/E (TTM)
-
P/S (TTM)
6.60
P/FCF (TTM)
9.49
Rev YoY
+78.7%
EPS YoY
+89.1%
Gross Margin
+93.1%
Op Margin
-12.0%
Net Debt
-$8.43M
Current Ratio
4.69
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology